Law RH, Ko AB, Jones LR, et al. - A prospective cohort study was performed from January 2017 to January 2019 to determine the impact of intranasal Doyle splints on postoperative pain following septoplasty and inferior turbinate reduction (ITR), as well as to assess changes in Nasal Obstruction Symptom Evaluation (NOSE) scores. Patients were enrolled if they had nasal obstruction due to septal deviation and inferior turbinate hypertrophy, and a one-month intranasal corticosteroid trial failed. Participants in the study were 57 patients (37 splints, 20 no-splints). Data reported that the median postoperative pain VAS score was 3.0 for the splint group and 4.0 for the no-splint group. It was noted that the median postoperative pain medication demand in morphine equivalents at the first postoperative visit was 5.4 mg/day for the splint group and 8.4 mg/day for the no-splint group. No statistically significant differences were found in postoperative pain VAS scores or pain medication use between the two groups. All patients experienced significant postoperative reductions in NOSE scores.